Announcements Trials
Browse Landscape

Phase

Phase 2 87Phase 3 43Phase 1/2 9Phase 1 9Phase NA 2Phase 4 2Phase 2/3 2

Status

Withdrawn 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Recurrence 1Leukemia, Myeloid, Acute 1Carcinoma, Hepatocellular 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 258Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 145Surgical Procedures, Operative 134Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Radiotherapy, Intensity-Modulated 79Colonoscopy 79Specimen Handling 78Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Interventional × Interferon-alpha × Clear all
NCT03121079 2020-09-23

Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation

Peking University People's Hospital

Phase NA Withdrawn
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT00838968 2012-08-23

The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma

Fudan University

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡